MedTrace Logo

Computerized Antibiotic Stewardship Study

NCT03120975 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16176

Last updated 2020-11-19

No results posted yet for this study

Summary

Prescribing antibiotics frequently poses problems in practice, since patients don't always receive the right dosage of the right antibiotic for the right period of time. This promotes the emergence and spread of antibiotic resistance. The investigators of this trial aim to develop a system designed to help doctors to use antibiotics more appropriately. Under COMPASS (COMPuterized Antibiotic Stewardship Study), doctors in three Swiss hospitals will receive tips on the use of antibiotics that are integrated directly into electronic health record and will also be given regular feedback on their use of antibiotics. Parallel to this, data on the antimicrobial prescription practices of a control group which is not using the system will be collected.

Conditions

  • Communicable Diseases

Interventions

OTHER

Computerized decision support and audit & feedback

* suggestion of guideline concordant antimicrobial treatment based on indication entry in the computerized physician order entry system * mandatory reevaluation of antimicrobial therapy therapy on calendar day 4 of treatment * suggestion of standard antimicrobial treatment duration according to indication

OTHER

Audit & Feedback

\* regular (at least monthly) feedback of antibiotic use quality indicators (on the ward level)

OTHER

Standard antibiotic stewardship

* Infectious diseases consultation "on demand" * Review of positive blood cultures * Availability of a antibiotic use guidelines (on paper and as PDF)

Sponsors & Collaborators

  • Benedikt Huttner

    lead OTHER

  • Swiss National Science Foundation

    collaborator OTHER

  • University of Geneva, Switzerland

    collaborator OTHER

  • Ente Ospedaliero Cantonale, Ticino, Switzerland

    collaborator OTHER

Principal Investigators

  • Benedikt D Huttner, MD, MS · Geneva University Hospitals and University of Geneva

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-03
Primary Completion
2020-02-29
Completion
2020-03-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03120975 on ClinicalTrials.gov